ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

CMMB Stock Ownership Breakdown

NASDAQ : CMMB

Chemomab Therapeutics Ltd.

$1.12

-0.04-3.45%

At Close 4:00 PM

81.49

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

CMMB Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares1.36

Short Percent Of Float1.37

Shares Outstanding18.86M

Shares Float260.67M

Shares Short255.94K

Short Ratio1.65

1.37%

Short % of Float

1.36%

Short % of Shares Outstanding

Market Insider CMMB

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

11.29% Percentage of Shares held by All Insiders

27.99% Percentage of Shares held by All Institutions

31.55% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 27.99% of CMMB shares are held by financial institutions. ADVISORY SERVICES NETWORK, LLC is the top corporate investor, holding 4.79K shares valued at $2.44K. A 0.04% stake in Chemomab Therapeutics Ltd. is owned by the company. ADVISORY SERVICES NETWORK, LLC owns 11.17K shares valued at $10.00K, which translates its holding of 0.1% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Dec 31, 2023	ADVISORY SERVICES NETWORK, LLC	0.04%	4.79K	2.44K	-6.39K	-57.16%
Sep 30, 2023	ADVISORY SERVICES NETWORK, LLC	0.1%	11.17K	10K	0	0

CMMB Insiders

Among the CMMB insiders holding of 11.29% of the stake in company, ORBIMED ISRAEL GP LTD., director, holds the largest shares of 2.24M. MOR GEORGE ADI, Chief Scientific Officer, is the second largest CMMB insider with ownership of 251.15K shares. THIEL PETER, 10 percent owner, stands third with possession of 23.05K shares of that stake.

Insiders	Designation	Shares Held
ORBIMED ISRAEL GP LTD.	director	2.24M
MOR GEORGE ADI	Chief Scientific Officer	251.15K
THIEL PETER	10 percent owner	23.05K
COHEN NEIL HARRIS	director	10K
PFOST DALE R	Chief Executive Officer	1.8K
MARVIN DONALD	Executive VP, CFO & COO	1.75K
MARYLES JOEL MICHAEL		1.43K
DARVISH NISSIM		1.2K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Jan 03, 2023	ORBIMED ISRAEL GP LTD.	SALE	4.51	70.52K	318.06K	2.24M
Jan 03, 2023	MOR GEORGE ADI	SALE	5.03	6.1K	30.66K	251.15K
Nov 16, 2022	COHEN NEIL HARRIS	SALE	2.00	2.41K	4.82K	10K
Nov 16, 2022	MOR GEORGE ADI	SALE	2.08	257.25K	536.31K	257.25K
May 24, 2022	MARYLES JOEL MICHAEL	PURCHASE	2.76	33	91.08	1.43K
May 18, 2022	COHEN NEIL HARRIS	PURCHASE	3.19	2K	6.38K	12.41K
Mar 18, 2022	MARYLES JOEL MICHAEL	PURCHASE	4.36	500	2.18K	1K
Mar 16, 2022	MARVIN DONALD	PURCHASE	3.30	250	825	1.75K
Mar 14, 2022	PFOST DALE R	PURCHASE	3.98	1.8K	7.16K	1.8K
Mar 14, 2022	COHEN NEIL HARRIS	PURCHASE	4.20	2K	8.4K	6.41K
Mar 14, 2022	MARVIN DONALD	PURCHASE	4.00	250	1K	250
Mar 11, 2022	DARVISH NISSIM	PURCHASE	4.28	1.2K	5.14K	1.2K
Dec 06, 2021	COHEN NEIL HARRIS	PURCHASE	7.43	2K	14.86K	4.41K
Mar 16, 2021	COHEN NEIL HARRIS	PURCHASE	13.17	688	9.06K	688
Mar 16, 2021	THIEL PETER	PURCHASE	17.35	23.05K	400.01K	23.05K

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.